- 501. cancer therapy
- [Any intervention for management of a malignant neoplasm. ( NCI )] (UMLS (CSP) C0920425) Cancer Treatment;
Malignant Neoplasm Therapy;
Malignant Neoplasm Treatment =Therapeutic or Preventive Procedure ;
| - 551. Cannabis dependence
- (UMLS (ICD9CM) C0006870) =Mental or Behavioral Dysfunction
|
- 502. cancer therapy in children, long term effects secondary to
- (UMLS (NCI) C0280954) =Finding
| - 552. Cannabis dependence, episodic use
- [ ] (UMLS (ICD9CM) C0338758) =Mental or Behavioral Dysfunction
|
- 503. cancer thermotherapy
- [ ] (UMLS (CSP) C0920739) =Therapeutic or Preventive Procedure ;
| - 553. Cannabis dependence, in remission
- [ ] (UMLS (ICD9CM) C0154490) =Disease or Syndrome
|
- 504. cancer transplantation
- [ ] (UMLS (CSP) C0920693) =Research Activity
| - 554. Cannabis dependence, unspecified use
- [ ] (UMLS (ICD9CM) C0375174) =Mental or Behavioral Dysfunction
|
- 505. Cancer with Regional Lymph Node Involvement
- (UMLS (NCI) C1332837) =Neoplastic Process ;
| - 555. Cannot Be Determined
- [Cannot distinguish between two or more possible values in the current context. ( NCI )] (UMLS (NCI) C0205258) =Idea or Concept
|
- 506. Cancer, Oncology
- [the study or science of neoplastic growth; for thorough searching see RTs. ( CSP )] (UMLS (NCI) C0278627) =Biomedical Occupation or Discipline =Medical Science;
=cellular oncology;
molecular oncology;
| - 556. Cannula
- (UMLS (HL7) C1546577) =Intellectual Product =Specimen Source Codes;
|
- 507. Cancer-Promoting Gene
- [endogenous or acquired genes whose presence or activation leads to neoplastic transformation; compare with TUMOR SUPPRESSOR GENE and PROTOONCOGENE. ( CSP )] (UMLS (NCI) C0029016) =Gene or Genome ;
=gene;
| - 557. Cannula
- (UMLS (HL7) C1550232) =Body Part, Organ, or Organ Component =Body Part;
◊ (UMLS (HL7) C1550622) Body Substance SpecimenEntityType; |
- 508. Cancer/Testis Antigen 1B Gene
- [Expressed in testis and ovary (0.8-kb mRNA), 3-exon 8-kb human CTAG Gene (CTAG Family) encodes 180-aa Cancer/Testis Antigen 1, with 1 putative transmembrane domain. (NCI) ( NCI )] (UMLS (NCI) C1413787) CTAG1B;
CTAG1B Gene =Gene or Genome | - 558. cannulation
- [ ] (UMLS (CSP) C0917707) =Therapeutic or Preventive Procedure
|
- 509. Cancerous Tumor of Blood Vessel
- [A malignant neoplasm arising from the vascular tissue. It is characterized by vascular channel formation and malignant endothelial cells. ( NCI )] (UMLS (NCI) C1334630) Malignant Tumor of Blood Vessel;
Malignant Vascular Neoplasm;
Malignant Vascular Tissue Neoplasm;
Malignant Vascular Tissue Tumor;
Malignant Vascular Tumor;
Vascular Neoplasms, Malignant;
=Neoplastic Process ;
| - 559. Cannulation of pancreatic duct
- (UMLS (ICD9CM) C0176945) =Therapeutic or Preventive Procedure
|
- 510. Cancerphobia
- (UMLS (NCI) C0233705) =Mental or Behavioral Dysfunction
| - 560. Cannulation of thoracic duct
- (UMLS (ICD9CM) C0193891) =Therapeutic or Preventive Procedure
|
- 511. CancerVax
- [CancerVax is an allogenic polyvalent vaccine composed of irradiated but viable cells from three melanoma cell lines and Bacille Calmette-Guerin (BCG). The vaccine was shown to induce humoral and cellular immune responses against multiple tumor antigens present on melanoma cells. A significant correlation between the magnitude of immune responses to the vaccine and the overall survival of patients receiving adjuvant therapy with CancerVax after surgical resection of stage III and IV melanoma was reported. Vaccine testing in patients with advanced colon cancer merits further investigation. (NCI) ( NCI )] (UMLS (NCI) C0796453) C-VAX;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 561. Cano Delgadito virus
- [ ] (UMLS (CSP) C0872124) =Virus ;
|
- 512. CANCRUM ORIS
- [A severe gangrenous process occurring predominantly in debilitated and malnourished children, especially in underdeveloped countries. It typically begins as a small vesicle or ulcer on the gingiva that rapidly becomes necrotic and spreads to produce extensive destruction of the buccal and labial mucosa and tissues of the face, which may result in severe disfigurement and even death. Various bacteria have been implicated in the etiology. (Dorland, 27th ed) ( MSH )] (UMLS (ICD9CM) C0028271) =Disease or Syndrome ;
=Mouth Diseases;
| - 562. Canola Oil
- [Vegetable oil developed from rapeseed plant. ( NCI )] (UMLS (NCI) C0054599) =Lipid; Pharmacologic Substance =Fatty Acids, Monounsaturated;
Inactive Ingredient Preparations =ISOSOURCE LIQUID (CLOSED SYSTEM);
FIBERSOURCE HN LIQUID;
FIBERSOURCE LIQUID;
ISOSOURCE HN LIQUID (CLOSED SYSTEM);
ULTRACAL TUBE-FEEDING LIQUID;
ISOSOURCE HN LIQUID (VANILLA);
PROMOTE LIQUID VANILLA |
- 513. Candela
- [The candela is the basic unit of luminous intensity, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). It is the luminous intensity in a given direction of a monochromatic light small source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second. ( NCI )] (UMLS (NCI) C0700300) =Quantitative Concept ;
=UnitOfMeasureAtomBaseUnitSens;
UnitOfMeasureAtomBaseUnitInsens | - 563. CANTHOTOMY
- (UMLS (ICD9CM) C0197075) =Therapeutic or Preventive Procedure
|
- 514. Candesartan Cilexetil
- [A synthetic antihypertensive benzimidazole-carboxylate derivative, Candesartan Cilexetil (Candesartan prodrug) selectively blocks angiotensin ll binding to specific receptors, inducing vasodilation and reduced aldosterone production. With other hypotensive agents, it is indicated in hypertension. (NCI04) ( NCI )] (UMLS (NCI) C0527379) =Organic Chemical; Pharmacologic Substance ;
=2-Ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-benzoimidazole-4-carboxylic Acid;
Unclassified Ingredients =CANDESARTAN CILEXETIL 16 MG;
CANDESARTAN CILEXETIL 32 MG;
CANDESARTAN CILEXETIL 4 MG;
CANDESARTAN CILEXETIL 8 MG;
| - 564. Canthus
- (UMLS (HL7) C0229245) =Body Location or Region =Body Part;
|
- 515. Candida
- [genus of yeast-like mitosporic fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores; commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including candidiasis. ( CSP )] (UMLS (CSP) C0006836) =Fungus ;
=yeast;
[DX300] DIAGNOSTIC ANTIGENS;
Unclassified Ingredients;
=Candida albicans;
CANDIDA ANTIGEN;
Candida albicans;
CANDIDA ANTIGEN;
| - 565. Cao Dai
- (UMLS (HL7) C1552042) =Idea or Concept =Religious Affiliation;
|
- 516. Candida albicans
- [etiologic agent of candidiasis. ( CSP )] (UMLS (CSP) C0006837) =Fungus ;
=Candida;
=CANDIDA ALBICANS SKIN TEST;
CANDIDA ALBICANS 1:1000 UNT/ML;
| - 566. CAP
- [A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI) ( NCI )] (UMLS (NCI) C0006935) =Biomedical or Dental Material ;
=PILL;
=Oral Capsule |
- 517. Candida Albicans Skin Test Reagent
- [A culture filtrate of cells of Candida Albicans propagated in a chemically defined medium and used as a recall antigen to evaluate cellular immunity in infection, cancer, and other disease states. (NCI) ( NCI )] (UMLS (NCI) C0879601) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid
| - 567. CAP 100
- [ ] (UMLS (CSP) C0599673) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 518. Candida Esophagitis
- (UMLS (NCI) C0239295) =Disease or Syndrome
| - 568. CAP ER
- [A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) ( NCI )] (UMLS (NCI) C0991505) CAPSULE, EXTENDED RELEASE;
Extended Release Capsule;
Extended Release Capsule Dosage Form;
Extended Release Capsule Dose Form;
=Biomedical or Dental Material =Oral Capsule;
=Extended Release Enteric Coated Capsule;
24 Hour Extended Release Capsule;
12 Hour Extended Release Capsule;
Extended Release Enteric Coated Capsule;
24 Hour Extended Release Capsule;
12 Hour Extended Release Capsule;
|
- 519. CANDIDAL ENDOCARDITIS
- [ ] (UMLS (ICD9CM) C0153254) =Disease or Syndrome
| - 569. Cap type
- (UMLS (HL7) C1547773) =Idea or Concept =HL7 Vocabulary Version 2.5;
|
- 520. CANDIDAL ENTERITIS
- [ ] (UMLS (ICD9CM) C0343886) =Disease or Syndrome
| - 570. CAP Z
- [ ] (UMLS (CSP) C0599674) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 521. CANDIDAL MENINGITIS
- [ ] (UMLS (ICD9CM) C0153256) =Disease or Syndrome
| - 571. CAP-1
- [Carcinoembryonic antigen peptide-1. A protein that can stimulate an immune response. ( NCI )] (UMLS (NCI) C0393002) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 522. CANDIDAL OTITIS EXTERNA
- [ ] (UMLS (ICD9CM) C0153255) =Disease or Syndrome
| - 572. CAP-1-6D Peptide
- [A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA. ( NCI )] (UMLS (NCI) C0935801) Carcinoembryonic Antigen Peptide 1-6D;
CEA:571-579 (576D);
mCEA Peptide;
Modified CEA Peptide =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 523. CANDIDAL VULVOVAGINITIS
- [Infection of the vulva and vagina with a fungus of the genus CANDIDA. It is a disease associated with HIV infection. ( NCI )] (UMLS (ICD9CM) C0700345) =Disease or Syndrome =candidiasis;
vagina disorder;
Vulvar Disease;
| - 573. CAP-1/HBsAg
- (UMLS (NCI) C0796321) Carcinoembryonic Antigen Peptide 1/Hepatitis B Antigen Peptide;
=Therapeutic or Preventive Procedure |
- 524. Candidate Disease Gene
- [A gene proposed to have a primary role in a disease, based upon its known function in other organisms or model systems or based upon its physical proximity to markers linked to a genetic disease. ( NCI )] (UMLS (NCI) C1332838) Candidate Gene;
Candidate Genes;
Target Gene;
=Gene or Genome ;
| - 574. CAP-I
- (UMLS (NCI) C0280547) =Therapeutic or Preventive Procedure
|
- 525. CANDIDIAS UROGENITAL NEC
- [ ] (UMLS (ICD9CM) C0153250) =Disease or Syndrome
| - 575. CAP43
- [Expressed most prominently in placenta, prostate, kidney, small intestine, and ovary, human NDRG1 Gene (NDRG Family, Alpha/Beta Hydrolase Superfamily) encodes ubiquitous cytoplasmic N-Myc Downstream Regulated Protein 1, also associated with the plasma membrane and nucleus. Downregulated by NMYC and rapidly induced by okadaic acid, a serine/threonine phosphatase inhibitor, increased NDRG1 levels are induced by an elevation of free intracellular calcium ion; cells that border lumenae show highest expression. Involved in stress responses, hormone responses, cell growth, and differentiation, NDRG1 may have a growth inhibitory role. (NCI) ( NCI )] (UMLS (NCI) C0916139) Differentiation-Related Gene 1 Protein;
DRG1;
NDR1;
NDRG1;
NDRG1 Protein;
Nickel-Specific Induction Protein CAP43;
N-Myc Downstream Regulated Protein 1;
Protein Regulated By Oxygen-1;
Reducing Agents and Tunicamycin-Responsive Protein;
RIT42;
RTP;
Tunicamycin-Responsive Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 526. candidiasis
- [infection with a fungus of the genus Candida; usually a superficial infection of the moist areas of the body and is generally caused by Candida albicans; includes chronic mucocutaneous candidiasis, cutaneous candidiasis, oral candidiasis (thrush), and monilial vaginitis. ( CSP )] (UMLS (CSP) C0006840) =Disease or Syndrome =Fungal Infection;
opportunistic infection;
Disease (VD), venereal;
=Candidiasis, Chronic Mucocutaneous;
Candidiasis, Cutaneous;
Candidiasis of mouth;
CANDIDAL VULVOVAGINITIS;
| - 576. capacitance
- [The ability of a substrate to retain an electrical charge. ( MSH )] (UMLS (CSP) C0242264) =Quantitative Concept
|
- 527. CANDIDIASIS OF LUNG
- [ ] (UMLS (ICD9CM) C0153251) =Disease or Syndrome
| - 577. CAPD
- [portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. ( CSP )] (UMLS (CSP) C0031140) =Therapeutic or Preventive Procedure ;
=Dialysis;
|
- 528. Candidiasis of mouth
- [A condition in which Candida albicans, a type of yeast, grows out of control in moist skin areas of the body. It is usually a result of a weakened immune system, but can be a side effect of chemotherapy or treatment with antibiotics. Thrush usually affects the mouth (oral thrush); however, rarely, it spreads throughout the entire body. Also called Candidiasis or Candidosis. ( NCI )] (UMLS (ICD9CM) C0006849) =Disease or Syndrome =candidiasis;
Mouth Diseases | - 578. CAPE VERDE
- [A group of islands in the North Atlantic Ocean, west of Senegal. (NCI) ( NCI )] (UMLS (NCI) C0006893) =Geographic Area ;
|
- 529. Candidiasis of other specified sites
- [ ] (UMLS (ICD9CM) C0153253) =Disease or Syndrome
| - 579. CAPE/TXT
- (UMLS (NCI) C0796483) Capecitabine/Docetaxel =Therapeutic or Preventive Procedure
|
- 530. Candidiasis of skin and nails
- (UMLS (ICD9CM) C0006842) =Disease or Syndrome
| - 580. Capecitabine/Carboplatin/Epirubicin
- (UMLS (NCI) C1134604) =Therapeutic or Preventive Procedure
|
- 531. canid herpesvirus
- [ ] (UMLS (CSP) C0597803) =Virus ;
| - 581. Capecitabine/Celecoxib/Gefitinib
- (UMLS (NCI) C1134669) =Therapeutic or Preventive Procedure
|
- 532. Canidae
- [Taxonomic family which includes the domestic dog, wolves and foxes. ( NCI )] (UMLS (NCI) C0524515) =Mammal
| - 582. Capecitabine/Celecoxib/Irinotecan
- (UMLS (NCI) C1327989) =Therapeutic or Preventive Procedure ;
|
- 533. canine
- [The domestic dog Canis familiaris. ( NCI )] (UMLS (CSP) C0012984) =Mammal
| - 583. Capecitabine/Cyclophosphamide/Epirubicin
- (UMLS (NCI) C0935742) =Therapeutic or Preventive Procedure
|
- 534. canine (dental)
- [One of the four pointed conical teeth (two in each jaw) located between the incisors and the premolars. ( NCI )] (UMLS (CSP) C0010482) =Body Part, Organ, or Organ Component
| - 584. Capecitabine/DJ-927
- (UMLS (NCI) C1328114) =Therapeutic or Preventive Procedure; ;
|
- 535. canine coronavirus
- [A species of CORONAVIRUS infecting dogs. Onset of symptoms is usually sudden and includes vomiting, diarrhea, and dehydration. ( MSH )] (UMLS (CSP) C0206421) =Virus
| - 585. Capecitabine/Docetaxel/Tipifarnib
- (UMLS (NCI) C1328052) =Therapeutic or Preventive Procedure ;
|
- 536. canine distemper virus
- [A species of MORBILLIVIRUS causing distemper in dogs, wolves, foxes, raccoons, and ferrets. Pinnipeds have also been known to contract Canine distemper virus from contact with domestic dogs. ( MSH )] (UMLS (CSP) C0012755) =Virus ;
| - 586. Capecitabine/Fluorouracil/Leucovorin Calcium/Oxaliplatin
- (UMLS (NCI) C1327741) =Therapeutic or Preventive Procedure ;
|
- 537. canine herpesvirus
- [A species of VARICELLOVIRUS virus that causes a disease in newborn puppies. ( MSH )] (UMLS (CSP) C0006861) =Virus
| - 587. Capecitabine/Gemcitabine
- (UMLS (NCI) C1134568) =Therapeutic or Preventive Procedure
|
- 538. canine parvovirus
- [A species of the genus PARVOVIRUS and a host range variant of FELINE PANLEUKOPENIA VIRUS. It causes a highly infectious fulminating ENTERITIS in dogs producing high mortality. It is distinct from CANINE MINUTE VIRUS, a species in the genus BOCAVIRUS. This virus can also infect cats and mink. ( MSH )] (UMLS (CSP) C0206466) =Virus ;
| - 588. Capecitabine/GTI-2040
- (UMLS (NCI) C1327950) =Therapeutic or Preventive Procedure; ;
|
- 539. Canister
- [A pressurized metal container holding a substance released as a spray or aerosol. ( HL7V3.0 )] (UMLS (HL7) C1556079) =Intellectual Product =MultiUseContainerEntityType;
| - 589. Capecitabine/Irinotecan
- (UMLS (NCI) C0796639) =Therapeutic or Preventive Procedure
|
- 540. CANISTER
- [A type of can for holding a drug product. ( NCI )] (UMLS (NCI) C0336640) =Manufactured Object
| - 590. Capecitabine/Irinotecan/Oxaliplatin
- (UMLS (NCI) C0935719) =Therapeutic or Preventive Procedure
|
- 541. cannabinoid
- [terpene constituents of Cannabis. ( CSP )] (UMLS (CSP) C0006864) =Organic Chemical =alkaloid;
benzopyran;
hallucinogen;
terpene =(-)-.DELTA.9-Tetrahydrocannabinol | - 591. Capecitabine/Ixabepilone
- (UMLS (NCI) C1327804) =Therapeutic or Preventive Procedure ;
|
- 542. cannabinoid receptor
- [receptor specific for delta-9- tetrahydrocannabinol and its' analogs. ( CSP )] (UMLS (CSP) C0054594) =Amino Acid, Peptide, or Protein; Receptor =drug receptor;
| - 592. Capecitabine/LY317615
- (UMLS (NCI) C1327831) =Therapeutic or Preventive Procedure ;
|
- 543. cannabinol
- [A physiologically inactive constituent of Cannabis sativa L. ( MSH )] (UMLS (CSP) C0006865) =Organic Chemical; Pharmacologic Substance ;
| - 593. Capecitabine/Oxaliplatin
- (UMLS (NCI) C0879259) =Therapeutic or Preventive Procedure
|
- 544. Cannabis
- [plant genus of the family Cannabacae and the dried flowering tops which contain hallucinogens. ( CSP )] (UMLS (CSP) C0936079) =Plant =angiosperm;
| - 594. Capecitabine/Paclitaxel
- (UMLS (NCI) C0879478) =Therapeutic or Preventive Procedure ;
|
- 545. Cannabis abuse
- (UMLS (ICD9CM) C0006868) =Disease or Syndrome
| - 595. Capecitabine/Paclitaxel/Trastuzumab
- (UMLS (NCI) C0879603) =Therapeutic or Preventive Procedure
|
- 546. Cannabis abuse, continuous use
- [ ] (UMLS (ICD9CM) C0154520) =Mental or Behavioral Dysfunction
| - 596. Capecitabine/Tipifarnib
- (UMLS (NCI) C1328150) =Therapeutic or Preventive Procedure ;
|
- 547. Cannabis abuse, episodic use
- [ ] (UMLS (ICD9CM) C0154521) =Mental or Behavioral Dysfunction
| - 597. Capecitabine/Vinorelbine
- (UMLS (NCI) C0796645) =Therapeutic or Preventive Procedure
|
- 548. Cannabis abuse, in remission
- [ ] (UMLS (ICD9CM) C0154522) =Finding
| - 598. Capgras Syndrome
- [A psychotic disorder characterized by the patient's belief that acquaintances or closely related persons have been replaced by doubles or imposters. ( MSH )] (UMLS (NCI) C0006895) =Mental or Behavioral Dysfunction ;
=Schizophrenia and Disorders with Psychotic Features;
|
- 549. Cannabis abuse, unspecified use
- [ ] (UMLS (ICD9CM) C0375179) =Mental or Behavioral Dysfunction
| - 599. capi33i I
- (UMLS (NCI) C0338307) =Therapeutic or Preventive Procedure
|
- 550. CANNABIS DEPEND-CONTIN
- [ ] (UMLS (ICD9CM) C0338757) =Mental or Behavioral Dysfunction
| - 600. CAPILLARIASIS
- (UMLS (ICD9CM) C0006897) =Disease or Syndrome ;
|
home
